Significance of nm23 mRNA expression in human hepatocellular carcinoma

Anticancer Research

Volumn 18, Issue 1 B, 1998, Pages 541-546

  Lin, Liang In ^a   Lee, Po Huang ^a   Wu, Ching Mei ^a   Lin, Jen Kun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cancer metastasis; Cancer progression; Hepatocellular carcinoma; nm23

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; METASTASIS POTENTIAL; PATHOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

AGED; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM INVASIVENESS; NUCLEOSIDE-DIPHOSPHATE KINASE; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0031900887     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 47: 1473-1487, 1987.
2. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
3. Gilles AM, Presecan E, Vonica A, Lascu I: Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biological Chem 266: 8784-8789, 1991.
4. MacDonald NJ, De la Rosa A, Benedict MA, Freije JM, Krutsch H, Steeg, PS. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268: 25780-25789, 1993.
5. Postel EH, Berberich SJ, Flint SJ, Ferrone CA: Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis [see comments]. Science 261: 478-480, 1993.
6. Steeg PS, Cohn KH, Leone A: Tumor metastasis and nm23: current concepts. [Review] [27 refs]. Cancer Cells 3: 257-262, 1991.
7. Okabe-Kado J, Kasukabe T, Baba H, Urano T, Shiku H, Honma Y: inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells. Biochim Biophys Acta 1267: 101-106, 1995.
8. Caligo MA, Cipollini G, Fiore L, Calvo S, Basolo F, Collecchi P, Ciardiello F, Pepe S, Petrini M, Bevilacqua G: NM23 gene expression correlates with cell growth rate and S-phase. Int J Cancer 60: 837-842, 1995.
9. Hirayama R, Sawai S, Takagi Y, Mishima Y, Kimura N, Shimada N, Esaki, Y, Kurashima C, Utsuyama M, Hirokawa K: Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst 83: 1249-1250, 1991.
10. Barnes R, Masood S, Barker E, Rosengard AM, Coggin DL, Crowell T, King CR, Porter-Jordan K, Wargotz ES, Liotta LA, et al. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Amer J Pathology 139: 245-250, 1991.
11. Hennessy C, Henry JA, May FE, Westley BR, Angus B, Lennard TW: Expression of anti-metastatic gene nm23 [letter; comment]. Brit J Cancer 63: 1024, 1991.
12. Keim D, Hailat N, Melhem R, Zhu XX, Lascu̇ I, Veron M, Strahler J, Hanash SM: Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 89: 919-924, 1992.
13. Bodey B, Bodey B, Jr., Groger AM, Siegel SE, Kaiser HE: Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology. Anticancer Res 17: 505-511, 1997.
14. Nakayama H, Yasui W, Yokozaki H, Tahara E: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Japanese J Cancer Res 84: 184-190, 1993.
15. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O: Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 52: 6088-6091, 1992.
16. Higashiyama M, Doi O, Yokouchi H, Kodama K, Nakamori S, Tateishi R, Kimura N: Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. British Journal of Cancer 66: 533-536, 1992.
17. AnonymousTNM Classfication of Malignant Tumors. Edited by Hermanek P, Sobin LH. Genova: UICC, 1987,.
18. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, et al: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clinical Investigation 88: 341-345, 1991.
19. Haut M, Steeg PS, Willson JK, Markowitz SD: Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 83: 712-716, 1991.
20. Mandai M, Konishi I, Komatsu T, Mon T, Arao S, Nomura H, Kanda Y, Hiai H, Fukumoto M: Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression. Brit J Cancer 72: 691-695, 1995.
21. AnonymousInternational Hemoglobin Information Center (IHIC) Variants list. Hemoglobin 19: 39-124, 1995.
22. Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K, Suzuki T: NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res 55: 652-657, 1995.
23. Yamaguchi A, Urano T, Goi T, Takeuchi K, Niimoto S, Nakagawara G, Furukawa K, Shiku H: Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer 73: 2280-2284, 1994.
24. Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii, N, Kimura N, Nagataki S: Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 84: 1349-1354, 1992.